Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
I have more shares than you that is for sure happy to prove it too… do you know anything about IMM and the value of Lupozor, you know Lupozor that Avion are happy to pay $25m to fund a phase 3 trial…. Pay £70m in milestone payments… pay double digit royalties… for US rights only, willing to invest £1.1m into IMM at 11p…. Their CEO stating he sees Lupozor as Avions future lead product…. I mean these things are interesting topics, a random share poster such as myself is not that interesting and unless your a women I don’t like attention off men but weird I don’t swing that way! For all those who want to see IMM succeed we are on the curb of something special here after years of false dawns, the rebuilding of the value of IMM is about to kick off here, your either in for the ride or sat out, either way it’s going to be one hell of a ride
Only numb buts would sell when over the next 3 weeks we have two company making announcements due that could see the price increase 5 fold, only a fool sells for fish and chip money and then looks on with envy as others eat steak and smoked salmon
Oh I love the attention is this the lambo board or IMM? I make money that’s what I do, I don’t sit around like a stuffed plum, tell you what same bet to you as Nolupus, £5000 says this hits 10p before the end of June, if you want to take the bet send me your Twitter name, took another £3k today will look to add again before tomorrow
Agree 5p is nailed, Positive news from FDA on CIDP trial today will be the spark that ignites this given 7th June FDA meeting is also now only 3 weeks away… it’s going to be quite a ride, all goes well and we will be well over 10p by mid June
MM don’t want to sell their shares at these prices… once this goes on a run there’s no stopping it, you either get in early or pay much higher on FDA news, very tight book looks ready just needs the volume and we are away with two company making catalysts due
Agree on all those points, from a value point of view if Avion are willing to stump up $25m plus the $1m they put into IMM at 11p… then the value of IMM has got to be far north of the current £9m Mcap, I’d suggest around £30m Mcap would be about right which is a 350% rise from current low levels, as Iv said you pay your money you take your chances but the risk reward ratio here is outstanding, not many shares out there offer potentially 3 fold increase in price within a 4 week period and that’s what we have here, during the run up to the last FDA meeting the price went from 5p to 7p and that was with selling from the 5p placing and options so it’s a safe bet that from 2.6p the only way is up as we move towards 7th June FDA approval meeting date, have a good weekend everyone nice to have a bit of sunshine for once!
Agree Pokerchips the main prize here is the 7th June meeting with the FDA for the Lupozor phase 3 trial approval, 3 long years in the making and imo the odds are that they will be happy with the protocol this time given the FDA have pretty much designed it!! What price on approval… well last year after the 5p placing the price hit 7p ahead of news so I assume 7p is the minimum we can expect, the CIDP trial is important as it has the strong possibility to bring in some funding from a licensing deal let’s say £5m upfront and pay for the CIDP trial and in return they get full rights and IMm get double digits royalties, with milestone payments similar to the $25m Avion deal with up to £70m in milestone payments and double digit royalties for the US rights to Lupozor, which really is a cracking deal for IMM probably the best deal Tim M has ever done in his life I think we can all agree on that!
Come on Nolupus take up my offer £5000 bet that the price is 10p or over by the end of June 2023, give me odds of 3/1 and we can sort it out over Twitter… if the FDA are positive on CIDP trial on Tuesday that will set us up for quite the bull run into Lupozor phase 3 trial fully funded by Avion for $25m, the plan is to secure a multimillion £ licensing deal for CIDP and ROW rights for Lupozor that would see IMM funded for many years to come with no dilution to existing holders, as I say you pay your money you take your chances but if it comes good then from £9m Mcap life changing gains are in offer here make no mistake about it
Oh and Nolupus I will write whatever I want, I’m here to make money that’s it, and with IMM if you know when to buy and sell it can be incredibly profitable, the most important 3 weeks in IMM history imo surely you just agree with that
Speak to Lisa Baderoon that’s all I can say Nolupus, oh btw I have an offer for you, you said it was 1000/1 on IMM hitting 10p by the end of June, I will stake £5000 that it’s 10p by the end of June if you fancy a flutter let me know what odds and send me your Twitter name we can get it set up
We look forward with optimism to 2023 and the Board has the clear objectives of advancing P140 (Lupuzor™) into its next clinical trial and in addition, also delivering positive advances across the whole portfolio in both clinical development and commercial partnerships.
In conjunction with these objectives, the Company has been continuing to manage its cost base which demonstrates a cash runway through the end of 2023 and into the first half of 2024.
Ok so firstly if you actually bother to contact the bod in particular Lisa Baderoon she will answer any questions you may have within reason. The results are to 31 December 2022, they put out an rns stating fully funded until early 2024…. On 23rd December 2022…. So I. Dry much doubt that between 23rd dec and 31 December a whole 8 days that their guidance has changed from fully funded to early 2024! The bod are not to my knowledge taking a salary at present, and costs have been cut right down. They also received a payment from Orion and Lanstead payments each month.we have the most important 3 weeks in the companies history coming up and you guys are talking about funding… do you really think funding will be a problem if they receive FDA approval for the CIDP to advance on Tuesday… do you think funding will be a problem if on 7th June they receive FDA approval for our Lupozor phase 3 trial in Lupus the most eagerly anticipated rns from IMM in over 3 years unlocking $25m of funding from Avion… the price will be well north of 10p by which point either a placing or a licensing deal would be no problem at all. If you listen to Tim’s interview in Feb he talks of receiving a cash lump sum as part of any new licensing deals…. Hence I am confident that they have a licensing deal lined up for CIDP which will be signed after the FDA meeting… the most important 3 weeks in the company’s history coming up and the opportunity to make life changing gains awaits those brave enough and researched well enough to back this and buy shares, the biggest risk is not taking any risk at all
We are not trading the last though we are Trading the present and future events the past is gone, with Avion funding the trial for $25m and 3 years of FDA guidance I think it has a good chance of coming good and if it does the rise here will be life changing for many to the upside this time